Effect on Parkinson's Disease After Therapeutic Induction of CranioSacral Integrated Therapy
Primary Purpose
Parkinson's Disease
Status
Enrolling by invitation
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
biweekly intervention
Sponsored by
About this trial
This is an interventional treatment trial for Parkinson's Disease focused on measuring Parkinson's disease, Craniosacral therapy, cranial osteopathy
Eligibility Criteria
Inclusion Criteria:
- must be Diagnosed with Parkinson's Disease
Exclusion Criteria:
- Anyone without Parkinson's Disease
Sites / Locations
- Naturalmed therapy
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
biweekly intervention
Arm Description
biweekly intervention
Outcomes
Primary Outcome Measures
reduction in tremors due to Parkinson's disease in the patient
Measurement of the tremors and quality of the coordination of the medial leminiscus system on 1-10 (1 being zero tremors and 10 being out of control tremors) scale at the evaluation and at beginning and at the end of each treatment session and in the end will provide a graphical and statistical display in the change in the tremors relative to the therapeutic induction
Secondary Outcome Measures
Quality of Proprioception
will evaluate the patients ability to move within space and time with certain precision and measure it on a scale of 1-10 (1 being very precise with fine motor movement and 10 being out of control fine motor movements)at the time of evaluation and at the beginning and end of each therapeutic treatment and finally document it graphically and statistically, the change in the overall motor movements like walking and quality of gait.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01989013
Brief Title
Effect on Parkinson's Disease After Therapeutic Induction of CranioSacral Integrated Therapy
Official Title
Effect on Parkinson's Disease After Therapeutic Induction of CranioSacral Integrated Therapy
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Enrolling by invitation
Study Start Date
February 2014 (undefined)
Primary Completion Date
March 2025 (Anticipated)
Study Completion Date
March 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Zia, Al Raza
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
We are studying & researching the effect of CranioSacral Integrative therapy on Parkinson's Diseased Patients for 3 months. With a therapeutic induction via manual CranioSacral integrative therapy for 90 minutes per session with a total of 2 session divided equally in a month (biweekly intervention). At the end of 3 months each patient will have total of 9 hours of CranioSacral Integrative therapy induced, we will document the symptoms and shortcomings of the patients at evaluation, before and after therapeutic treatment on a measured scale ranging from 1-10. Finally graphically and statistically measure the quality of change in the symptoms at the end of 3 months and provide executive summary of the research finding, which the investigators expect to be a positive one.
Detailed Description
We are studying & researching the effect of CranioSacral I therapy on Parkinson's Disease
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Parkinson's Disease
Keywords
Parkinson's disease, Craniosacral therapy, cranial osteopathy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
5 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
biweekly intervention
Arm Type
Other
Arm Description
biweekly intervention
Intervention Type
Other
Intervention Name(s)
biweekly intervention
Other Intervention Name(s)
manual therapy
Intervention Description
10 step craniosacral therapy protocol through manual therapy at feet , thoracic diaphragm, neck and cranium
Primary Outcome Measure Information:
Title
reduction in tremors due to Parkinson's disease in the patient
Description
Measurement of the tremors and quality of the coordination of the medial leminiscus system on 1-10 (1 being zero tremors and 10 being out of control tremors) scale at the evaluation and at beginning and at the end of each treatment session and in the end will provide a graphical and statistical display in the change in the tremors relative to the therapeutic induction
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Quality of Proprioception
Description
will evaluate the patients ability to move within space and time with certain precision and measure it on a scale of 1-10 (1 being very precise with fine motor movement and 10 being out of control fine motor movements)at the time of evaluation and at the beginning and end of each therapeutic treatment and finally document it graphically and statistically, the change in the overall motor movements like walking and quality of gait.
Time Frame
3 months
Other Pre-specified Outcome Measures:
Title
Overall emotional State and sleep quality
Description
will evaluate the overall emotional and sleeping habits on the measurement scale of 1-10 where 1 being emotionally stable and positive with 8 hours of quality sleep and 10 being emotionally unstable and have less than 4 hours of sleep at night and at the end of research will graphically and statistically provide the outcome of the above mentioned measure.
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
must be Diagnosed with Parkinson's Disease
Exclusion Criteria:
Anyone without Parkinson's Disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Al Raza, CST
Organizational Affiliation
IBR, Inc.
Official's Role
Principal Investigator
Facility Information:
Facility Name
Naturalmed therapy
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48104
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Effect on Parkinson's Disease After Therapeutic Induction of CranioSacral Integrated Therapy
We'll reach out to this number within 24 hrs